細胞裂解市場規模、佔有率及成長分析（依產品類型、細胞類型、應用、最終用戶及地區分類）－2026-2033年產業預測

預計到 2024 年，細胞裂解市場規模將達到 35.7 億美元，到 2025 年將達到 38.3 億美元，到 2033 年將達到 66.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.2%。

細胞裂解市場正經歷強勁成長，這主要得益於基因組學、蛋白質組學和細胞分析等多個研究領域對細胞裂解技術日益成長的需求。細胞裂解是提取重要的細胞內成分和生物分子（例如DNA、RNA、蛋白質和細胞器）的關鍵步驟，在分析和實驗應用中發揮至關重要的作用。藥物研發活動的激增、個人化醫療的興起以及生物技術的進步，都顯著推動了對高效、高品質細胞裂解方法的需求。此外，慢性病發生率的上升以及對精準診斷工具需求的增加，也進一步促進了市場擴張。細胞裂解技術的創新和自動化，將為市場未來的持續成長奠定基礎。

細胞裂解市場促進因素

推動全球細胞裂解市場發展的關鍵因素是製藥、生物技術和診斷等多個領域對基於細胞的研究和開發需求的激增。細胞裂解在分離細胞成分以進行後續分析和實驗方面發揮著至關重要的作用。隨著個人化醫療、藥物發現和基因組學研究的日益普及，細胞裂解的重要性與日俱增。此外，細胞裂解技術的不斷進步，包括以微珠為基礎的技術和高通量系統，透過提高研究方法的效率、擴充性和可重複性，正在推動市場擴張。這些趨勢共同為細胞裂解解決方案創造了蓬勃發展的環境。

限制細胞裂解市場的激素

全球細胞裂解市場面臨一項重大挑戰：相關產品和設備的高成本。各種技術都需要使用專用試劑、耗材和設備，這些成本可能非常高。對於預算有限的研究人員和實驗室，尤其是在發展中地區，這種經濟負擔可能構成重大障礙。此外，準確執行細胞裂解操作需要熟練的專業人員，這進一步增加了成本。這些因素可能會限制細胞裂解技術的應用，尤其是在資源匱乏的環境中，阻礙市場成長。

細胞裂解市場趨勢

細胞裂解市場正呈現自動化和高通量系統應用顯著成長的趨勢。隨著細胞生物學的日益複雜，研究人員越來越需要高效可靠的方法來破壞細胞膜並提取細胞內成分。自動化系統具有許多優勢，例如精確控制、可重複性和擴充性，從而簡化了細胞裂解流程。這種自動化不僅減少了人工操作，還增強了基因組學、蛋白質組學、藥物研發和診斷研究等多個應用領域的工作流程整合。隨著實驗室不斷追求更高的生產效率和一致、標準化的結果，對這些先進解決方案的需求預計將穩定成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球細胞裂解市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 消耗品
  • 試劑盒和試劑
  • 酵素
  • 清潔劑溶液
  • 其他
  • 一次性產品
  • 其他
• 裝置
  • 超音波處理設備
  • 均質機
  • 法式濾壓壺
  • 微射流發生器
  • 珠磨機
  • 其他設備

全球細胞裂解市場規模（依細胞類型分類）及複合年成長率（2026-2033 年）

• 哺乳動物細胞
• 微生物細胞
• 細菌細胞
• 其他細胞

全球細胞裂解市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 蛋白質純化與分離
• 細胞器分離
• 核酸分離與純化
• 其他應用

全球細胞裂解市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 研究所
• 生物製藥和生物技術
• 其他最終用戶

全球細胞裂解市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.（USA）
• Danaher Corporation（USA）
• Qiagen NV（Netherlands）
• Merck KGaA（Germany）
• Bio-Rad Laboratories, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Covaris, Inc.（USA）
• Parr Instrument Company（USA）
• Claremont BioSolutions, LLC（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Miltenyi Biotec（Germany）
• Sartorius AG（Germany）
• Beckman Coulter, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Promega Corporation（USA）
• Takara Bio Inc.（Japan）
• Cell Signaling Technology, Inc.（USA）
• Qsonica（USA）
• Lonza（Switzerland）
• STEMCELL Technologies Inc.（Canada）

結論與建議

Cell Lysis Market size was valued at USD 3.57 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 6.67 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The cell lysis market is experiencing robust growth, fueled by the escalating demand for cell lysis techniques across diverse research fields, including genomics, proteomics, and cell-based assays. Essential for extracting key intracellular components and biomolecules-such as DNA, RNA, proteins, and organelles-cell lysis plays a vital role in analysis and experimentation. The surge in drug discovery efforts, the move towards personalized medicine, and advancements in biotechnology significantly boost demand for efficient, high-quality cell lysis methods. Additionally, the rising incidence of chronic diseases and the growing need for precise diagnostic tools further propel the market's expansion. Innovations and automation in cell lysis technologies position the market favorably for sustained growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Lysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Lysis Market Segments Analysis

Global Cell Lysis Market is segmented by product, cell type, application, end user, research laboratories and institutes, biopharmaceutical and biotechnology companies, other end user and region. Based on product, the market is segmented into consumables and instruments. Based on cell type, the market is segmented into mammalian cells, microbial cells, bacterial cells and other cells. Based on application, the market is segmented into protein purification and isolation, cell organelle isolation, nucleic acid isolation and purification and other application. Based on end user, the market is segmented into Research Laboratories and Institutes, biopharmaceutical and biotechnology companies, other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Lysis Market

A significant factor propelling the global cell lysis market is the surging demand for cell-based research and development across diverse sectors such as pharmaceuticals, biotechnology, and diagnostics. Cell lysis plays a crucial role in isolating cellular components for in-depth analysis and experimentation, which is becoming increasingly vital due to the heightened emphasis on personalized medicine, drug discovery, and genomics research. Furthermore, ongoing advancements in cell lysis technologies, including bead-based techniques and high-throughput systems, are enhancing market expansion by providing improved efficiency, scalability, and reproducibility in research processes. These trends collectively contribute to a thriving environment for cell lysis solutions.

Restraints in the Cell Lysis Market

The global cell lysis market faces a significant challenge due to the high expenses linked to cell lysis products and equipment. The various techniques involved often necessitate the use of specialized reagents, consumables, and instruments, which can be prohibitively costly. This financial burden can be particularly daunting for researchers and laboratories operating on limited budgets, especially in less developed regions. Additionally, the requirement for skilled personnel to execute cell lysis procedures accurately further escalates costs. Such factors can restrict the adoption of cell lysis technologies and consequently impede market growth, especially in resource-limited environments.

Market Trends of the Cell Lysis Market

The cell lysis market is experiencing a notable trend toward the adoption of automated and high-throughput systems. Researchers increasingly require efficient and reliable methods for disrupting cell membranes to extract intracellular components, driven by the complexities of cellular biology. Automated systems present significant advantages, including precise control, reproducibility, and scalability, which streamline cell lysis processes. This automation not only reduces manual labor but also enhances workflow integration across diverse applications such as genomics, proteomics, drug discovery, and diagnostic research. As laboratories aim for improved productivity and consistent, standardized outcomes, the demand for these advanced solutions is anticipated to rise steadily.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Lysis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Kits And Reagents
  • Enzymes
  • Detergent Solutions
  • Others
  • Disposables
  • Others
• Instruments
  • Sonicators
  • Homogenizers
  • French Press
  • Microfluidizer
  • Bead Mill
  • Other Instruments

Global Cell Lysis Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Mammalian Cells
• Microbial Cells
• Bacterial Cells
• Other Cells

Global Cell Lysis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Protein Purification And Isolation
• Cell Organelle Isolation
• Nucleic Acid Isolation And Purification
• Other Application

Global Cell Lysis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Research Laboratories And Institutes
• Biopharmaceutical And Biotechnology
• Other End User

Global Cell Lysis Market Size & CAGR (2026-2033)

• North America (Product, Cell Type, Application, End User)
  • US
  • Canada
• Europe (Product, Cell Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Application, End User,)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covaris, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parr Instrument Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Claremont BioSolutions, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qsonica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations